Phase 3 study of Zelrix transdermal for the treatment of migraines - MPR
Links shared publicly online about this topic.
- 1,758total visits
Phase 3 study of Zelrix transdermal for the treatment of migraines - MPR
empr.com —
NuPathe Inc. announced data from its Phase 3 trial of Zelrix (sumatriptan transdermal patch) for the treatment of acute migraine.
View full resource at empr.com
Tags: Migraine, Migraine Medication, Triptans, Headache, Vascular Headache, Phase 3 Clinical Trial, Imigran, Imitrex
Most Recently Shared on September 10, 2009 at 7:25 pm By:
MPR News: Phase 3 study of Zelrix transdermal for the treatment of migraines: NuPathe Inc. announced da.. http://bit.ly/VOpjh
Advertisement
